title: Combine and Conquer: Double CTLA-4 and PD-1 Blockade Combined with Whole Tumor Antigen Vaccine Cooperate to Eradicate Tumors.
authors.affiliation: Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.|Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland.|Swiss Institute for Experimental Cancer Research at EPFL, Lausanne, Switzerland.
authors.forename: Krisztian
authors.initials: K
authors.lastname: Homicsko
authors.affiliation: Department of Pathology, University of Chicago, Chicago, Illinois.
authors.forename: Jaikumar
authors.initials: J
authors.lastname: Duraiswamy
authors.affiliation: Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.
authors.forename: Marie-Agnès
authors.initials: MA
authors.lastname: Doucey
authors.affiliation: Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland. George.Coukos@chuv.ch.|Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland.
authors.forename: George
authors.initials: G
authors.lastname: Coukos
mesh_terms: D000818:Animals; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors* / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D051379:Mice; D010051:Ovarian Neoplasms / Q000276:immunology / Q000628:therapy*; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors* / Q000276:immunology; D023041:Xenograft Model Antitumor Assays
chemical_list: D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D019496:Cancer Vaccines; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor